1AI — Algorae Pharmaceuticals Share News
0.000.00%
- AU$18.23m
- AU$14.29m
- AU$0.08m
Australia Stock Exchange release from LIVING CELL TECH : Quarterly Activity Report and Appendix 4C
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 09:17:24
Australia Stock Exchange release from LIVING CELL TECH : Notice of General Meeting/ Proxy Form
Brief: Living Cell Technologies Signs MoU With Nzeno, Secures Pig Cells For NTCELL Trial
Australia Stock Exchange release from LIVING CELL TECH : LCT Signs MOU with NZeno, Secures Pig Cells for NTCELL Trial
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 12:10:44
Australia Stock Exchange release from LIVING CELL TECH : Application for quotation of securities - LCT
Brief: Living Cell Technologies Secures Funding For Third Clinical Trial Of NTCELL In Parkinson's Disease
Australia Stock Exchange release from LIVING CELL TECH : Cleansing Notice
Australia Stock Exchange release from LIVING CELL TECH : Proposed issue of securities - LCT
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 09:53:03
Australia Stock Exchange release from LIVING CELL TECH : Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
Brief: Living Cell Technologies Seeks Trading Halt
Australia Stock Exchange release from LIVING CELL TECH : Trading Halt
Australia Stock Exchange release from LIVING CELL TECH : Pause in Trading
Australia Stock Exchange release from LIVING CELL TECH : 2021 Annual General Meeting
Australia Stock Exchange release from LIVING CELL TECH : Annual Report to shareholders
Australia Stock Exchange release from LIVING CELL TECH : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from LIVING CELL TECH : Notification of cessation of securities - LCT